|
|
You have requested access to the following
article:
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
.
The Lancet
, Volume
371
, Issue
9617
, Pages
998
-
1006
S
.
Yokota
,
T
.
Imagawa
,
M
.
Mori
,
T
.
Miyamae
,
Y
.
Aihara
,
S
.
Takei
,
N
.
Iwata
,
H
.
Umebayashi
,
T
.
Murata
,
M
.
Miyoshi
|